• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Multiple sclerosis: Real-world treatment patterns and outcomes

Multiple sclerosis: Real-world treatment patterns and outcomes

by Truveta staff | Aug 25, 2025 | Data

Multiple sclerosis (MS) affects approximately 1 million people in the United States, with women representing nearly 75% of patients. Over the past decade, consensus guidelines from leading MS experts have increasingly emphasized the importance of early intervention...
ISPE 2025: Real-world data survival patterns in glioblastoma patients

ISPE 2025: Real-world data survival patterns in glioblastoma patients

by Truveta Research | Aug 22, 2025 | Research, Research Insights

Authors: Mantas Dmukauskas, PhD ⊕Truveta, Inc, Bellevue, WA, Sarah Blach, MS ⊕Truveta, Inc, Bellevue, WA, Sunny Guin, PhD ⊕Truveta, Inc, Bellevue, WA, Amy Wu ⊕Truveta, Inc, Bellevue, WA The survival rate for patients with glioblastoma (GBM) differs significantly by...
ISPE 2025: Active surveillance of mosquito-borne diseases in the United States

ISPE 2025: Active surveillance of mosquito-borne diseases in the United States

by Truveta Research | Aug 22, 2025 | Research, Research Insights

Authors: Katie Kendrick, MPH ⊕Truveta, Inc, Bellevue, WA, Amy Sullivan, MS ⊕Truveta, Inc, Bellevue, WA, Sunny Guin, PhD ⊕Truveta, Inc, Bellevue, WA, Agnes Pastwa ⊕Truveta, Inc, Bellevue, WA, Sarah Platt, MS ⊕Truveta, Inc, Bellevue, WA Truveta Data is well-suited to...
ISPE 2025: Active surveillance of foodborne diseases in the United States

ISPE 2025: Active surveillance of foodborne diseases in the United States

by Truveta Research | Aug 22, 2025 | Research, Research Insights

Authors: Katie Kendrick, MPH ⊕Truveta, Inc, Bellevue, WA, Amy Sullivan, MS ⊕Truveta, Inc, Bellevue, WA, Sunny Guin, PhD ⊕Truveta, Inc, Bellevue, WA, Agnes Pastwa ⊕Truveta, Inc, Bellevue, WA, Sarah Platt, MS ⊕Truveta, Inc, Bellevue, WA Truveta Data is well-suited to...
ISPE 2025: A real-world risk stratification approach to pulmonary embolism using Truveta Data

ISPE 2025: A real-world risk stratification approach to pulmonary embolism using Truveta Data

by Truveta Research | Aug 22, 2025 | Research, Research Insights

Authors: Amy Austin, MS ⊕Truveta, Inc, Bellevue, WA, Emily Webber, PhD ⊕Truveta, Inc, Bellevue, WA, Sarah Blach, MS ⊕Truveta, Inc, Bellevue, WA, Jared Kern ⊕Truveta, Inc, Bellevue, WA, Sarah Platt, MS ⊕Truveta, Inc, Bellevue, WA, Sally Omidvar, MSPH, MS ⊕Truveta, Inc,...
« Older Entries

Share this


Recent posts

  • Truveta experts: Gestational diabetes screening in real-world practice
  • Non-small cell lung cancer: Biomarkers, treatments, and outcomes in real-world data
  • Johns Hopkins builds research community to explore new frontiers in health using Truveta Data

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.